Table 2 Comparison of patient demographics and baseline characteristics between group A and group C and between group B and group D
|  | Age ≤ 45 | Age > 45 | ||||
|---|---|---|---|---|---|---|
Group A Liver failure | Group C Liver cirrhosis | P value | Group B Liver failure | Group D Liver cirrhosis | P value | |
Sex (M/F) | 33/4 | 25/2 | 1.000 | 23/4 | 24/8 | 0.092 |
Age (years) | 35.11 ± 4.40 | 35.85 ± 4.80 | 0.523 | 49 (46 to 61) | 53.5 (50.3 to 65) | 0.053 |
ALT (U/L) | 110 (51 to 233.5) | 66 (33 to 225) | 0.157 | 71 (42 to 395) | 38.5 (18.5 to 52.8) | 0.000 |
AST (U/L) | 104 (73.5 to 155.5) | 81 (66 to 122) | 0.062 | 96 (59 to 161) | 55.5 (32.5 to 82.5) | 0.002 |
TBIL (mmol/L) | 419.3 ± 167.0 | 317.96 ± 179.28 | 0.023 | 407 (248 to 503) | 120.5 (53.8 to 444.5) | 0.002 |
PTA | 34 (27 to 42) | 42 (34 to 48) | 0.013 | 35 (28 to 43) | 43 (34 to 59) | 0.022 |
MELD | 27 (25 to 30) | 25 (21 to 26) | 0.002 | 27 (25 to 30) | 22 (17 to 26) | 0.000 |
AFP | 105.7 (36.5 to 219.7) | 85.0 (8.1 to 290.0) | 0.714 | 70.5 (7.5 to 200.6) | 7.8 (1.9 to 37.9) | 0.011 |